Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient
- Resource Type
- Abstract
- Source
- In
Blood 29 November 2018 132 Supplement 1:4065-4065 - Subject
- Language
- ISSN
- 0006-4971